Skip to main content
. 2017 Mar 7;8(21):34268–34282. doi: 10.18632/oncotarget.15965

Figure 6. Over-expression of piR-35127 and piR-46545 in lung cancer cells.

Figure 6

Treatment of lung cancer cell lines (A549, H2199, and HT520) and breast cancer cell lines (Hs578T and MDA-MB-231) with 500 nM of piR-35127 and piR-46545 mimic RNA oligos decreased cell proliferation of lung cancer cells as determined by the Alamar Blue assay. All experiments were done at least 3 independent times with n = 4 wells per treatment. The (*) indicates statistical significance compared to controls (scrambled piRNA), with a P < 0.05.